Zimmer Biomet (NYSE:ZBH) today posted third-quarter results that topped expectations for both sales and earnings and stood by its prior forecast for the rest of the year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,